Inherited Blood Disorders: Types, Symptoms & What to Know

Inherited blood disorders

Inherited blood disorders are genetic conditions passed from parents to children that disrupt how the body produces or uses blood cells, hemoglobin, or clotting factors. They affect roughly 5% of the global population as carriers, and the World Health Organization estimates that over 300,000 babies are born with severe hemoglobin disorders alone each year. If you have a family history of conditions like sickle cell disease, thalassemia, or hemophilia, understanding your risk is the first step toward proactive management.

These aren’t rare curiosities — they’re among the most common single-gene disorders worldwide. Some are mild enough to go undiagnosed for decades, while others cause life-threatening complications in infancy. The severity depends on which gene is affected, whether you inherited one or two copies of the mutation, and the specific type of disorder.

The Most Common Inherited Blood Disorders

Inherited blood disorders fall into three broad categories based on which blood component is affected: red blood cells, white blood cells, or clotting factors. Here’s a breakdown of the conditions you’re most likely to encounter:

Disorder What’s Affected Inheritance Pattern Estimated Global Carriers
Sickle Cell Disease Red blood cells (hemoglobin S) Autosomal recessive ~300 million (sickle cell trait)
Thalassemia Red blood cells (hemoglobin production) Autosomal recessive ~270 million
Hemophilia A & B Clotting factors VIII or IX X-linked recessive ~1 in 5,000 male births (Hemophilia A)
Von Willebrand Disease Von Willebrand clotting factor Autosomal dominant (usually) ~1% of the population
G6PD Deficiency Red blood cell enzyme X-linked recessive ~400 million
Hereditary Spherocytosis Red blood cell membrane Autosomal dominant ~1 in 2,000 (Northern Europeans)

Why Certain Populations Are More Affected

This is a question that comes up constantly, and the answer is evolutionary biology. Carrying one copy of the sickle cell gene (sickle cell trait) provides partial protection against Plasmodium falciparum malaria. Over thousands of years, this survival advantage caused the mutation to persist at high frequencies in malaria-endemic regions — sub-Saharan Africa, the Mediterranean, the Middle East, and South Asia.

The same principle applies to thalassemia carriers in Southeast Asia and the Mediterranean, and to G6PD deficiency across tropical and subtropical regions. Genetics doesn’t discriminate, but ancestry shapes which mutations you’re more likely to carry.

Symptoms That Should Raise a Red Flag

Symptoms vary dramatically depending on the specific disorder, but certain patterns should prompt testing:

Red Blood Cell Disorders (Sickle Cell, Thalassemia)

  • Chronic fatigue and pallor disproportionate to activity level
  • Jaundice (yellowing of eyes and skin) — caused by rapid red blood cell breakdown
  • Recurrent pain crises, especially in bones, chest, or abdomen (sickle cell)
  • Delayed growth in children or failure to thrive
  • Enlarged spleen — sometimes detected as left-sided abdominal fullness

Clotting Factor Disorders (Hemophilia, Von Willebrand Disease)

  • Prolonged bleeding after cuts, dental procedures, or surgery
  • Easy bruising — particularly large or deep bruises from minor trauma
  • Joint bleeding (hemarthrosis) — swollen, warm, stiff joints, especially knees, elbows, and ankles
  • Heavy menstrual periods lasting more than 7 days (often the first sign of Von Willebrand disease in women)
  • Nosebleeds lasting longer than 10 minutes

How Inherited Blood Disorders Are Diagnosed

Diagnosis typically starts with a complete blood count (CBC) and a peripheral blood smear, which can reveal abnormal cell shapes (like the crescent-shaped cells of sickle cell disease) or unusually small, pale red cells suggesting thalassemia.

From there, more specific tests are ordered based on clinical suspicion:

  • Hemoglobin electrophoresis — identifies abnormal hemoglobin variants (Hb S, Hb C, Hb E)
  • Coagulation studies — PT, aPTT, and specific factor levels for suspected bleeding disorders
  • Genetic testing — confirms the exact mutation and inheritance pattern; essential for family planning counseling
  • Newborn screening — all 50 U.S. states now screen for sickle cell disease at birth

If you have a known family history, carrier testing before or during pregnancy can identify whether both parents carry a recessive mutation. When both parents are carriers of sickle cell trait, for example, each pregnancy carries a 25% chance of producing a child with sickle cell disease.

Treatment Options in 2024

Treatment has evolved enormously. Options range from symptom management to outright cures:

  • Hydroxyurea — reduces pain crises in sickle cell disease by up to 50% and is now recommended starting at age 9 months
  • Regular blood transfusions — mainstay for severe thalassemia; patients may need transfusions every 2–4 weeks
  • Iron chelation therapy — prevents iron overload from chronic transfusions (ferritin targets typically below 1,000 ng/mL)
  • Factor replacement therapy — synthetic or plasma-derived clotting factors for hemophilia; newer extended half-life products allow less frequent dosing
  • Emicizumab (Hemlibra) — a bispecific antibody for hemophilia A that’s changed the game for prophylaxis, given subcutaneously rather than IV
  • Bone marrow transplant — the only established cure for sickle cell disease and thalassemia, though it requires a matched donor and carries significant risks
  • Gene therapy — the FDA approved Casgevy (CRISPR-based) and Lyfgenia for sickle cell disease in December 2023, marking a new era in curative treatment

When to See a Doctor

Don’t wait for a crisis. See a hematologist if:

  • You have a family history of any inherited blood disorder and haven’t been tested
  • You’re experiencing unexplained chronic fatigue with hemoglobin consistently below 10 g/dL
  • You bruise easily, bleed excessively during periods, or have prolonged bleeding after minor procedures
  • You and your partner are planning a pregnancy and both have ancestry from high-prevalence regions
  • Your child has failed to meet growth milestones or has recurrent unexplained fevers with anemia

Carrier testing is a simple blood test that typically costs under $200 out-of-pocket, and many insurance plans cover it when there’s a documented family history or relevant ancestry.

Frequently Asked Questions

Can you have an inherited blood disorder and not know it?

Absolutely. Carriers of recessive disorders like sickle cell trait or thalassemia minor often have no symptoms or only mild anemia. Von Willebrand disease — the most common inherited bleeding disorder — is estimated to affect 1% of the population, yet the majority remain undiagnosed because symptoms are often dismissed as “heavy periods” or “easy bruising.”

Are inherited blood disorders curable?

Some are. Bone marrow transplant can cure sickle cell disease and thalassemia in selected patients, and the 2023 FDA approval of CRISPR-based gene therapy (Casgevy) represents a potential one-time cure for sickle cell disease. Hemophilia doesn’t have a standard cure yet, but gene therapy trials (like Roctavian for hemophilia A) are showing sustained factor production for years after a single infusion.

If both parents are carriers, will their child definitely be affected?

No. For autosomal recessive conditions, when both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of being completely unaffected. Genetic counseling can map this out precisely based on the specific mutation.

Can inherited blood disorders skip a generation?

They can appear to. If both parents are silent carriers of a recessive condition and their children inherit only one copy, those children are carriers without symptoms. The disorder can then “reappear” if that carrier has children with another carrier. X-linked conditions like hemophilia can also seem to skip generations, passing silently through carrier females before manifesting in a grandson.

What’s the difference between sickle cell trait and sickle cell disease?

Sickle cell trait means you carry one normal hemoglobin gene (Hb A) and one sickle gene (Hb S). You typically have no symptoms and a normal lifespan. Sickle cell disease means you inherited two abnormal genes (Hb SS, or combinations like Hb SC) and will experience chronic anemia, pain crises, and organ damage without treatment. Trait is not a mild form of the disease — they are fundamentally different clinical entities.

Written by
Haematology, Immunology, Inflammation, Platelet Biology
Home Contact pcunin@bwh.harvard.edu cuninpierre pierre Pierre Cunin Brigham and Women’s Hospital and Harvard Medical School May 15, 2020 Megakaryocytes as immune cells Research in immunology and cell biology – Instructor at Harvard Medical School.
View Full Profile →

Related Posts